BOLD vs CCI · P/E 0.1, $24.6M cap vs P/E 40, rev $6.57B
Boundless Bio, Inc. Common Stock (BOLD) versus Crown Castle (CCI) — a side-by-side from cached financials, not a winner call.
Boundless Bio, Inc. Common Stock (BOLD) is a biotechnology company listed on US.
Crown Castle (CCI) is a reit - specialty company listed on US.
BOLD does not have a complete income-statement cache yet.
Latest reported CCI revenue for 2024-12-31 was $6.57B. Net income was -$3.90B. Revenue was down 5.9% from 2023-12-31 to 2024-12-31. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
BOLD currently screens at market cap $24.6M and trailing P/E 0.1. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Not investment advice. Open the BOLD and CCI stock pages for the full models.
Not investment advice.